A retrospective cohort study in the USA investigated the 1-year treatment outcomes with GLP-1 RA according to baseline insulin use in people with T2D who initiated exenatide OW or liraglutide OD [69]
It attributes that spread to metabolic factors and lifestyle adherence rather than to the medication alone
What this policy shift changes, what it doesnt, and why womens health has been written out of every version of this conversation until now
Common Side Effects Mild nausea (most common, usually improves within a few weeks) Diarrhea or constipation due to slowed digestion Bloating or fullness after meals Mild headaches or fatigue Less Common But Serious Side Effects Pancreatitis (rare) Watch for persistent, severe abdominal pain. Hypoglycemia (rare in non-diabetics) Can occur when combined with insulin therapy. Allergic reactions (very rare) Monitor for rash, swelling, or difficulty breathing
ask your pharmacy whether smaller-gauge needles are available
Scientific publications describe BPC-157 within preclinical or experimental research environments
